7-138733046-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020632.3(ATP6V0A4):​c.1739T>C​(p.Met580Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0592 in 1,613,950 control chromosomes in the GnomAD database, including 3,999 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M580I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.091 ( 1002 hom., cov: 31)
Exomes 𝑓: 0.056 ( 2997 hom. )

Consequence

ATP6V0A4
NM_020632.3 missense

Scores

3
9
5

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:7

Conservation

PhyloP100: 9.32

Publications

29 publications found
Variant links:
Genes affected
ATP6V0A4 (HGNC:866): (ATPase H+ transporting V0 subunit a4) This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of intracellular compartments of eukaryotic cells. V-ATPase dependent acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A and three B subunits, two G subunits plus the C, D, E, F, and H subunits. The V1 domain contains the ATP catalytic site. The V0 domain consists of five different subunits: a, c, c', c'', and d. This gene is one of four genes in man and mouse that encode different isoforms of the a subunit. Alternatively spliced transcript variants encoding the same protein have been described. Mutations in this gene are associated with renal tubular acidosis associated with preserved hearing. [provided by RefSeq, Jul 2008]
ATP6V0A4 Gene-Disease associations (from GenCC):
  • renal tubular acidosis, distal, 3, with or without sensorineural hearing loss
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal recessive distal renal tubular acidosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0022696257).
BP6
Variant 7-138733046-A-G is Benign according to our data. Variant chr7-138733046-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 5154.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.191 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020632.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP6V0A4
NM_020632.3
MANE Select
c.1739T>Cp.Met580Thr
missense
Exon 17 of 22NP_065683.2
ATP6V0A4
NM_130840.3
c.1739T>Cp.Met580Thr
missense
Exon 16 of 21NP_570855.2
ATP6V0A4
NM_130841.3
c.1739T>Cp.Met580Thr
missense
Exon 16 of 21NP_570856.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP6V0A4
ENST00000310018.7
TSL:1 MANE Select
c.1739T>Cp.Met580Thr
missense
Exon 17 of 22ENSP00000308122.2
ATP6V0A4
ENST00000353492.4
TSL:1
c.1739T>Cp.Met580Thr
missense
Exon 16 of 21ENSP00000253856.6
ATP6V0A4
ENST00000393054.5
TSL:5
c.1739T>Cp.Met580Thr
missense
Exon 16 of 21ENSP00000376774.1

Frequencies

GnomAD3 genomes
AF:
0.0908
AC:
13799
AN:
152026
Hom.:
992
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.194
Gnomad AMI
AF:
0.0471
Gnomad AMR
AF:
0.0554
Gnomad ASJ
AF:
0.0985
Gnomad EAS
AF:
0.0560
Gnomad SAS
AF:
0.119
Gnomad FIN
AF:
0.0365
Gnomad MID
AF:
0.0981
Gnomad NFE
AF:
0.0455
Gnomad OTH
AF:
0.0900
GnomAD2 exomes
AF:
0.0658
AC:
16551
AN:
251412
AF XY:
0.0666
show subpopulations
Gnomad AFR exome
AF:
0.198
Gnomad AMR exome
AF:
0.0376
Gnomad ASJ exome
AF:
0.0939
Gnomad EAS exome
AF:
0.0546
Gnomad FIN exome
AF:
0.0371
Gnomad NFE exome
AF:
0.0458
Gnomad OTH exome
AF:
0.0601
GnomAD4 exome
AF:
0.0559
AC:
81714
AN:
1461806
Hom.:
2997
Cov.:
41
AF XY:
0.0571
AC XY:
41515
AN XY:
727222
show subpopulations
African (AFR)
AF:
0.192
AC:
6431
AN:
33476
American (AMR)
AF:
0.0397
AC:
1774
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0926
AC:
2419
AN:
26136
East Asian (EAS)
AF:
0.0679
AC:
2694
AN:
39700
South Asian (SAS)
AF:
0.119
AC:
10234
AN:
86258
European-Finnish (FIN)
AF:
0.0366
AC:
1953
AN:
53420
Middle Eastern (MID)
AF:
0.104
AC:
602
AN:
5768
European-Non Finnish (NFE)
AF:
0.0464
AC:
51548
AN:
1111934
Other (OTH)
AF:
0.0672
AC:
4059
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
4530
9059
13589
18118
22648
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2152
4304
6456
8608
10760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0910
AC:
13851
AN:
152144
Hom.:
1002
Cov.:
31
AF XY:
0.0908
AC XY:
6756
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.194
AC:
8052
AN:
41456
American (AMR)
AF:
0.0554
AC:
846
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0985
AC:
342
AN:
3472
East Asian (EAS)
AF:
0.0559
AC:
289
AN:
5168
South Asian (SAS)
AF:
0.118
AC:
568
AN:
4818
European-Finnish (FIN)
AF:
0.0365
AC:
387
AN:
10606
Middle Eastern (MID)
AF:
0.0986
AC:
29
AN:
294
European-Non Finnish (NFE)
AF:
0.0455
AC:
3096
AN:
68022
Other (OTH)
AF:
0.0942
AC:
199
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
602
1204
1807
2409
3011
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
152
304
456
608
760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0612
Hom.:
1921
Bravo
AF:
0.0959
TwinsUK
AF:
0.0456
AC:
169
ALSPAC
AF:
0.0496
AC:
191
ESP6500AA
AF:
0.185
AC:
817
ESP6500EA
AF:
0.0479
AC:
412
ExAC
AF:
0.0691
AC:
8390
Asia WGS
AF:
0.137
AC:
476
AN:
3478
EpiCase
AF:
0.0478
EpiControl
AF:
0.0468

ClinVar

Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 16611712, 27884173, 10973252, 20981092, 24252324)

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:2
Dec 10, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal recessive distal renal tubular acidosis Benign:2
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 25, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign.

Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss Pathogenic:1
Sep 01, 2000
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.34
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Uncertain
-0.010
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.60
D
Eigen
Uncertain
0.59
Eigen_PC
Uncertain
0.66
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.92
D
MetaRNN
Benign
0.0023
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Pathogenic
3.0
M
PhyloP100
9.3
PrimateAI
Uncertain
0.59
T
PROVEAN
Uncertain
-2.8
D
REVEL
Pathogenic
0.65
Sift
Benign
0.032
D
Sift4G
Uncertain
0.040
D
Polyphen
0.77
P
Vest4
0.26
MPC
0.41
ClinPred
0.051
T
GERP RS
5.8
Varity_R
0.42
gMVP
0.74
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3807153; hg19: chr7-138417791; COSMIC: COSV59474048; COSMIC: COSV59474048; API